COX-2 inhibitors - PDFSEARCH.IO - Document Search Engine

COX-2 inhibitors
Results: 152

#	Item
51	Disclosure Document for an 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:20 Arthritis Connective tissue diseases COX-2 inhibitors Non-steroidal anti-inflammatory drugs Celecoxib G. D. Searle & Company Juvenile idiopathic arthritis Rheumatoid arthritis Health Medicine Pfizer
52	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:21 Arthritis Connective tissue diseases Rheumatology COX-2 inhibitors Celecoxib G. D. Searle & Company Rheumatoid arthritis Juvenile idiopathic arthritis Food and Drug Administration Health Medicine Pfizer
53	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Language: English Pfizer Anatomy Arthritis Connective tissue diseases COX-2 inhibitors Celecoxib Juvenile idiopathic arthritis Rheumatoid arthritis G. D. Searle & Company Medicine Health Rheumatology
54	DEPARTMENT OF HEALTH & HUMAN SERVICES MEMORANDUM Public Health Service Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:15 Arthritis Rheumatology Pfizer Sulfonamides Celecoxib Juvenile idiopathic arthritis Rheumatoid arthritis Rofecoxib Valdecoxib Health Medicine COX-2 inhibitors
55	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:24 Arthritis Connective tissue diseases Rheumatology Anatomy COX-2 inhibitors Celecoxib Juvenile idiopathic arthritis G. D. Searle & Company Rheumatoid arthritis Medicine Health Pfizer
56	http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSear Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-28 08:35:58 Non-steroidal anti-inflammatory drugs Pharmacology Organofluorides Pfizer Sulfonamides Celecoxib Rofecoxib Parecoxib Naproxen COX-2 inhibitors Chemistry Organic chemistry
57	--- Hypothesis Celecoxib Clinical Efficacy and Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-11-05 12:00:35 Non-steroidal anti-inflammatory drugs COX-2 inhibitors Celecoxib Organofluorides Pyrazoles Osteoarthritis Rheumatoid arthritis WOMAC Naproxen Medicine Health Arthritis
58	In order to align with the financial reporting periods of the majority of organisations, from this year we are disclosing payments by calender year, rather than by our financial reporting year (which runs from 1st st st Add to Reading List Source URL: www.pfizer.co.uk Language: English - Date: 2014-03-27 14:22:27 COX-2 inhibitors Sulfonamides Celecoxib Atrial fibrillation Stroke Medicine Economy of the United States Health Pfizer Corporate crime Dow Jones Industrial Average
59	Rx CIT Phase II Final Report Table of Contents Section Page Add to Reading List Source URL: wahealthalliance.org Language: English - Date: 2014-08-20 04:42:12 Pharmaceutical sciences Organofluorides Pfizer Selective serotonin reuptake inhibitors Pharmacy Compliance Antidepressant COX-2 inhibitor Pharmaceutical drug Medicine Pharmacology Chemistry
60	MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-11-17 09:59:24 Clinical research Pharmacology Pfizer Sulfonamides Clinical pharmacology Rofecoxib Celecoxib Valdecoxib Medical prescription COX-2 inhibitors Medicine Chemistry

UPDATE